How to apply the EULAR and ACR recommendations for the diagnosis and treatment of giant cell arteritis?
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
---|---|
Enthalten in: |
La Revue de medecine interne - 43(2022), 3 vom: 11. März, Seite 135-138 |
Sprache: |
Französisch |
---|
Weiterer Titel: |
Comment appliquer les recommandations EULAR et ACR pour le diagnostic et le traitement de l’artérite à cellules géantes ? |
---|
Beteiligte Personen: |
Samson, M [VerfasserIn] |
---|
Links: |
---|
Themen: |
Artérite à cellules géantes |
---|
Anmerkungen: |
Date Completed 17.03.2022 Date Revised 31.05.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.revmed.2022.02.004 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM337416567 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM337416567 | ||
003 | DE-627 | ||
005 | 20231225234347.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||fre c | ||
024 | 7 | |a 10.1016/j.revmed.2022.02.004 |2 doi | |
028 | 5 | 2 | |a pubmed24n1124.xml |
035 | |a (DE-627)NLM337416567 | ||
035 | |a (NLM)35210106 | ||
035 | |a (PII)S0248-8663(22)00036-4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a fre | ||
100 | 1 | |a Samson, M |e verfasserin |4 aut | |
245 | 1 | 0 | |a How to apply the EULAR and ACR recommendations for the diagnosis and treatment of giant cell arteritis? |
246 | 3 | 3 | |a Comment appliquer les recommandations EULAR et ACR pour le diagnostic et le traitement de l’artérite à cellules géantes ? |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 17.03.2022 | ||
500 | |a Date Revised 31.05.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Artérite à cellules géantes | |
650 | 4 | |a Giant cell arteritis | |
650 | 4 | |a Tocilizumab | |
650 | 4 | |a Traitement | |
650 | 4 | |a Treatment | |
700 | 1 | |a Bonnotte, B |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t La Revue de medecine interne |d 1983 |g 43(2022), 3 vom: 11. März, Seite 135-138 |w (DE-627)NLM012660108 |x 1768-3122 |7 nnns |
773 | 1 | 8 | |g volume:43 |g year:2022 |g number:3 |g day:11 |g month:03 |g pages:135-138 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.revmed.2022.02.004 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 43 |j 2022 |e 3 |b 11 |c 03 |h 135-138 |